Evidence map›Paper›PMID 14870965›Full record

ArticleJournal of muscle research and cell motility2003

Myosin phosphatase and myosin phosphorylation in differentiating C2C12 cells.

Yue Wu, Ferenc Erdodi, Andrea Murányi, Kevin D Nullmeyer, Ronald M Lynch, David J Hartshorne

Open access · greenAbstract read
PubMed Publisher
In one paragraph

Article in Journal of muscle research and cell motility, 2003. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
1.0field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 27 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Myosin phosphatase target subunit: Many roles in cell function.Biochemical and biophysical research communications · 2008
    Review
  9. Article
  10. Localization of myosin phosphatase target subunit and its mutants.Journal of muscle research and cell motility · 2005
    Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 2 countries.

Yue WuMuscle Biology Group, University of Arizona, Tucson, AZ 85721, USA.
Ferenc Erdodi
Andrea Murányi
Kevin D Nullmeyer
Ronald M Lynch
David J Hartshorne
University of Arizona · USUniversity of Debrecen · HU

Funding

BIOCHEMISTRY OF CONTRACTILE PROTEINSR01HL023615 · NHLBI · UNIVERSITY OF ARIZONA · PI HARTSHORNE, DAVID JOHN · 1985 to 2009
$2.8M
NA-PUMP ISOFORM-SPECIFIC REGULATION OF VASCULAR FUNCTIONR01HL066044 · NHLBI · UNIVERSITY OF CINCINNATI · PI PAUL, RICHARD JEROME · 2001 to 2004
$1.5M
NHLBI NIH HHS HL23615NHLBI NIH HHS HL66044
6 · The paper itself

Abstract

C2C12 cells offer a useful model to study the differentiation of non-muscle cells to skeletal muscle cells. Myosin phosphorylation and changes in related enzymes, with an emphasis on myosin phosphatase (MP) were analyzed over the first 6 days of C2C12 differentiation. There was a transition from myosin phosphatase target subunit 1 (MYPT1), predominant in the non-muscle cells to increased expression of MYPT2. Levels of MYPT1/2 were estimated, and both isoforms were higher in non- or partially differentiated cells compared to the concentrations in the differentiated isolated myotubes from day 6. A similar profile of expression was estimated for the type 1 protein phosphatase catalytic subunit, delta isoform (PP1c delta). Phosphatase activities, using phosphorylated smooth and skeletal muscle myosins, were estimated for total cell lysates and isolated myotubes. In general, smooth muscle myosin was the preferred substrate. Although the expression of MYPT1/2 and PP1c delta was considerably reduced in isolated myotubes the phosphatase activities were not reduced to corresponding levels. Most of the MP activity was due to PP1c, as indicated by okadaic acid. In spite of relatively high expression of MYPT1/2 and PP1c delta, marked phosphorylation of non-muscle myosin (over 50% of total myosin) was observed at day 2 (onset of expression of muscle-specific proteins) and both mono- and diphosphorylated light chains were observed. Partial inhibition of MLCK by 1-(5-chloronaphthalene-1-sulphonyl)-1H-hexahydro-1,4-diazepine HCl (ML-9) or by a construct designed from the autoinhibitory domain of MLCK, resulted in an increase in small myotubes (3-5 nuclei) after 3 days of differentiation and a decrease in larger myotubes (compared to control). The effect of ML-9 was not due to a reduction in intracellular Ca2+ levels. These results suggest that phosphorylation of non-muscle myosin is important in growth of myotubes, either in the fusion process to form larger myotubes or indirectly, by its role in sarcomere organization.

Indexed as

AnimalsAzepinesCalciumCatalytic DomainCell DifferentiationCells, CulturedEnzyme ActivationEnzyme InhibitorsMuscle Fibers, SkeletalMuscle, SkeletalMyosin-Light-Chain KinaseMyosin-Light-Chain PhosphataseMyosinsPhosphoprotein PhosphatasesPhosphorylationProtein Phosphatase 1AzepinesCalciumEnzyme InhibitorsML 9Myosin-Light-Chain KinaseMyosin-Light-Chain PhosphataseMyosinsPhosphoprotein PhosphatasesProtein Phosphatase 1

Identifiers

PMID14870965
OpenAlexW2064376756

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.